Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells through Wnt Signaling Pathway

View through CrossRef
Abstract Objective: To compare and analyze the effect of N-cadherin on chondrogenic differentiation of bone marrow derived mesenchymal stem cells (BMSCs) and to explore the related mechanism, so as to provide a novel theoretical basis for the clinical work of articular cartilage injury regeneration and repair.Methods: The experimental animals were clean grade SD rats (aged 5-6 weeks, weighing 180-250g). Alcian blue staining was carried out to observe the induced chondrogenesis following N-cadherin inhibition. The specific role of N-cadherin in Wnt signaling pathway and chondrogenic differentiation of BMSCs was detected by Western blot; while the effect of N-cadherin on the molecular level changes of β-catenin in cytoplasm was evaluated by fluorescence quantitative real-time PCR (qRT-PCR). In addition, immunocoprecipitation (IP) was used for the verification of the interaction between N-cadherin and β-catenin.Results: Under the light microscope, 90% of the BMSCs at the third generation, 90% of the cells were fused. Alcian blue staining showed that the green staining area in BMP2 induction group was large and dense, while that in N-cadherin inhibition group and blank control group was small and sparse. Western blot revealed that N-cadherin and SOX9 were significantly developed in BMP2 induction group, but Wnt3a was not significantly developed. While in N-cadherin inhibition group, the development of Wnt3a was obvious, yet without evident development of N-cadherin and SOX9. qRT-PCR indicated that the relative mRNA expression of Wnt3a was significantly increased in N-cadherin inhibition group (P<0.05). However, no obvious difference was observed in the mRNA expression of β-catenin between BMP2 induction group and N-cadherin inhibition group (P>0.05). Western blot indicated that in BMP2 induction group, there existed the development of β-catenin, significant development of phos-GSK-3β and total GSK-3β, but no obvious development of Wnt3a. In N-cadherin inhibition group, there were significantly enhanced development of Wnt3a and β-catenin than that before, blurred development of phos-GSK-3β than that before, and also obvious development of total GSK-3β with little change from before. N-cadherin promoted the expression of β-catenin mostly in the cell membrane, but only a few in the cytoplasm and nucleus. Additionally, verification by IP showed that N-cadherin and β-catenin were developed on N-cadherin and β-catenin bands, suggesting an interaction between N-cadherin and β-catenin. Conclusion: To sum up, N-cadherin can inhibit Wnt signaling pathway by inhibiting hub factors of this pathway. Wnt signaling pathway can inhibit chondrogenic differentiation of BMSCs. Collectively, N-cadherin can ultimately promotes chondrogenic differentiation of BMSCs by inhibiting Wnt signaling pathway.
Title: Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Description:
Abstract Objective: To compare and analyze the effect of N-cadherin on chondrogenic differentiation of bone marrow derived mesenchymal stem cells (BMSCs) and to explore the related mechanism, so as to provide a novel theoretical basis for the clinical work of articular cartilage injury regeneration and repair.
Methods: The experimental animals were clean grade SD rats (aged 5-6 weeks, weighing 180-250g).
Alcian blue staining was carried out to observe the induced chondrogenesis following N-cadherin inhibition.
The specific role of N-cadherin in Wnt signaling pathway and chondrogenic differentiation of BMSCs was detected by Western blot; while the effect of N-cadherin on the molecular level changes of β-catenin in cytoplasm was evaluated by fluorescence quantitative real-time PCR (qRT-PCR).
In addition, immunocoprecipitation (IP) was used for the verification of the interaction between N-cadherin and β-catenin.
Results: Under the light microscope, 90% of the BMSCs at the third generation, 90% of the cells were fused.
Alcian blue staining showed that the green staining area in BMP2 induction group was large and dense, while that in N-cadherin inhibition group and blank control group was small and sparse.
Western blot revealed that N-cadherin and SOX9 were significantly developed in BMP2 induction group, but Wnt3a was not significantly developed.
While in N-cadherin inhibition group, the development of Wnt3a was obvious, yet without evident development of N-cadherin and SOX9.
qRT-PCR indicated that the relative mRNA expression of Wnt3a was significantly increased in N-cadherin inhibition group (P<0.
05).
However, no obvious difference was observed in the mRNA expression of β-catenin between BMP2 induction group and N-cadherin inhibition group (P>0.
05).
Western blot indicated that in BMP2 induction group, there existed the development of β-catenin, significant development of phos-GSK-3β and total GSK-3β, but no obvious development of Wnt3a.
In N-cadherin inhibition group, there were significantly enhanced development of Wnt3a and β-catenin than that before, blurred development of phos-GSK-3β than that before, and also obvious development of total GSK-3β with little change from before.
N-cadherin promoted the expression of β-catenin mostly in the cell membrane, but only a few in the cytoplasm and nucleus.
Additionally, verification by IP showed that N-cadherin and β-catenin were developed on N-cadherin and β-catenin bands, suggesting an interaction between N-cadherin and β-catenin.
Conclusion: To sum up, N-cadherin can inhibit Wnt signaling pathway by inhibiting hub factors of this pathway.
Wnt signaling pathway can inhibit chondrogenic differentiation of BMSCs.
Collectively, N-cadherin can ultimately promotes chondrogenic differentiation of BMSCs by inhibiting Wnt signaling pathway.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
This study aimed to compare and analyze the effect of N-cadherin on chondrogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) and to explore the related me...
N-Cadherin Immunoexpression In Patients With Acute Myeloid Leukemia
N-Cadherin Immunoexpression In Patients With Acute Myeloid Leukemia
Abstract Introduction N-cadherin is a member of the cadherin family which is involved in calcium ion dependent adhesion between ...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Abstract 1590: N-cadherin is a key marker for epithelial-to-mesenchymal transition in clinical prostate cancer
Abstract 1590: N-cadherin is a key marker for epithelial-to-mesenchymal transition in clinical prostate cancer
Abstract Purpose of the study: Epithelial-to-mesenchymal transition (EMT) is characterized by E cadherin downregulation and simultaneous upregulation of mesenchymal ...
Differential marker expression by cultures rich in mesenchymal stem cells
Differential marker expression by cultures rich in mesenchymal stem cells
AbstractBackgroundMesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of mesenchymal stem cells in clinical practice requires...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...

Back to Top